Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014.


Journal Article

The First Annual Neonatal Scientific Workshop focused on the needs of the neonate by addressing the basic question: what information is required to inform decision making both at the regulatory level and at the bedside? Priority therapeutic areas include neonatal lung, brain, and gastrointestinal injury, retinopathy of prematurity, sepsis, and neonatal abstinence syndrome. Scientific progress in these therapeutic areas, regulatory standards, and the acceptable design and conduct of clinical trials must be aligned. This report will review potential approaches to enhancing neonatal drug development.

Full Text

Duke Authors

Cited Authors

  • Offringa, M; Davis, JM; Turner, MA; Ward, R; Bax, R; Maldonado, S; Sinha, V; McCune, SK; Zajicek, A; Benjamin, DK; Bucci-Rechtweg, C; Nelson, RM

Published Date

  • September 2015

Published In

Volume / Issue

  • 49 / 5

Start / End Page

  • 623 - 631

PubMed ID

  • 30227031

Pubmed Central ID

  • 30227031

Electronic International Standard Serial Number (EISSN)

  • 2168-4804

Digital Object Identifier (DOI)

  • 10.1177/2168479015597730


  • eng

Conference Location

  • Switzerland